Nationally ranked
Our pediatric diabetes and endocrinology program ranked 47th nationally in the 2022–23 U.S. News & World Report Best Children’s Hospitals survey.
Improved patient experiences with telemedicine
A UC Davis Health study led by Stephanie Crossen, M.D., M.P.H., pediatric endocrinologist and Clinical and Translational Science Center scholar, found that Type 1 diabetes patients felt their experiences with video visits during the COVID-19 pandemic were as effective or more effective than in-person care. The findings, published in Endocrines, also showed that 82% of patients hoped to use telemedicine in the future.
New diabetic ketoacidosis guidelines
In October, the International Society for Pediatric and Adolescent Diabetes (ISPAD) released its clinical consensus guidelines on the treatment of diabetic ketoacidosis (DKA). Published in the journal of Pediatric Diabetes, the guide includes recommendations for fluid and electrolyte replacement, insulin therapy and monitoring for complications. Nicole Glaser, M.D., pediatric endocrinologist at UC Davis Children’s Hospital, was the lead author of the published guidelines.
